| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.083 | 0.007 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |